271 related articles for article (PubMed ID: 26549027)
1. Cytoplasmic PML promotes TGF-β-associated epithelial-mesenchymal transition and invasion in prostate cancer.
Buczek ME; Miles AK; Green W; Johnson C; Boocock DJ; Pockley AG; Rees RC; Hulman G; van Schalkwyk G; Parkinson R; Hulman J; Powe DG; Regad T
Oncogene; 2016 Jun; 35(26):3465-75. PubMed ID: 26549027
[TBL] [Abstract][Full Text] [Related]
2. PMLIV overexpression promotes TGF-β-associated epithelial-mesenchymal transition and migration in MCF-7 cancer cells.
Liu Y; Wang JX; Huang D; Wang B; Li LL; Li XX; Ni P; Dong XL; Xia W; Yu CX; Xu WL; Chu WF; Zhao D
J Cell Physiol; 2018 Dec; 233(12):9575-9583. PubMed ID: 29943817
[TBL] [Abstract][Full Text] [Related]
3. Cytoplasmic PML function in TGF-beta signalling.
Lin HK; Bergmann S; Pandolfi PP
Nature; 2004 Sep; 431(7005):205-11. PubMed ID: 15356634
[TBL] [Abstract][Full Text] [Related]
4. [Promyelocytic leukaemia protein and defect in transforming growth factor-beta signal pathway in acute promyelocytic leukaemia].
Fuchs O; Provazníková D; Peslová G
Cas Lek Cesk; 2005; 144(2):90-4. PubMed ID: 15807293
[TBL] [Abstract][Full Text] [Related]
5. The metastasis suppressor CD82/KAI1 represses the TGF-β
Lee MS; Lee J; Kim YM; Lee H
Prostate; 2019 Sep; 79(12):1400-1411. PubMed ID: 31212375
[TBL] [Abstract][Full Text] [Related]
6. Vasohibin-2 is required for epithelial-mesenchymal transition of ovarian cancer cells by modulating transforming growth factor-β signaling.
Norita R; Suzuki Y; Furutani Y; Takahashi K; Yoshimatsu Y; Podyma-Inoue KA; Watabe T; Sato Y
Cancer Sci; 2017 Mar; 108(3):419-426. PubMed ID: 28064471
[TBL] [Abstract][Full Text] [Related]
7. Transforming growth factor-β promotes aggressiveness and invasion of clear cell renal cell carcinoma.
Sitaram RT; Mallikarjuna P; Landström M; Ljungberg B
Oncotarget; 2016 Jun; 7(24):35917-35931. PubMed ID: 27166254
[TBL] [Abstract][Full Text] [Related]
8. Generation of In Vitro Model of Epithelial Mesenchymal Transition (EMT) Via the Expression of a Cytoplasmic Mutant Form of Promylocytic Leukemia Protein (PML).
Di Biase A; Miles AK; Regad T
Methods Mol Biol; 2018; 1692():129-138. PubMed ID: 28986893
[TBL] [Abstract][Full Text] [Related]
9. An novel inhibitor of TGF-β type I receptor, IN-1130, blocks breast cancer lung metastasis through inhibition of epithelial-mesenchymal transition.
Park CY; Min KN; Son JY; Park SY; Nam JS; Kim DK; Sheen YY
Cancer Lett; 2014 Aug; 351(1):72-80. PubMed ID: 24887560
[TBL] [Abstract][Full Text] [Related]
10. Elf5 inhibits TGF-β-driven epithelial-mesenchymal transition in prostate cancer by repressing SMAD3 activation.
Yao B; Zhao J; Li Y; Li H; Hu Z; Pan P; Zhang Y; Du E; Liu R; Xu Y
Prostate; 2015 Jun; 75(8):872-82. PubMed ID: 25728398
[TBL] [Abstract][Full Text] [Related]
11. TSC1 activates TGF-β-Smad2/3 signaling in growth arrest and epithelial-to-mesenchymal transition.
Thien A; Prentzell MT; Holzwarth B; Kläsener K; Kuper I; Boehlke C; Sonntag AG; Ruf S; Maerz L; Nitschke R; Grellscheid SN; Reth M; Walz G; Baumeister R; Neumann-Haefelin E; Thedieck K
Dev Cell; 2015 Mar; 32(5):617-30. PubMed ID: 25727005
[TBL] [Abstract][Full Text] [Related]
12. Dasatinib blocks transcriptional and promigratory responses to transforming growth factor-beta in pancreatic adenocarcinoma cells through inhibition of Smad signalling: implications for in vivo mode of action.
Bartscht T; Rosien B; Rades D; Kaufmann R; Biersack H; Lehnert H; Gieseler F; Ungefroren H
Mol Cancer; 2015 Nov; 14():199. PubMed ID: 26588899
[TBL] [Abstract][Full Text] [Related]
13. JAK/STAT3 signaling is required for TGF-β-induced epithelial-mesenchymal transition in lung cancer cells.
Liu RY; Zeng Y; Lei Z; Wang L; Yang H; Liu Z; Zhao J; Zhang HT
Int J Oncol; 2014 May; 44(5):1643-51. PubMed ID: 24573038
[TBL] [Abstract][Full Text] [Related]
14. Loss of phosphatase and tensin homologue increases transforming growth factor beta-mediated invasion with enhanced SMAD3 transcriptional activity.
Hjelmeland AB; Hjelmeland MD; Shi Q; Hart JL; Bigner DD; Wang XF; Kontos CD; Rich JN
Cancer Res; 2005 Dec; 65(24):11276-81. PubMed ID: 16357132
[TBL] [Abstract][Full Text] [Related]
15. Transforming growth factor-β-induced plasticity causes a migratory stemness phenotype in hepatocellular carcinoma.
Malfettone A; Soukupova J; Bertran E; Crosas-Molist E; Lastra R; Fernando J; Koudelkova P; Rani B; Fabra Á; Serrano T; Ramos E; Mikulits W; Giannelli G; Fabregat I
Cancer Lett; 2017 Apr; 392():39-50. PubMed ID: 28161507
[TBL] [Abstract][Full Text] [Related]
16. OSR1 phosphorylates the Smad2/3 linker region and induces TGF-β1 autocrine to promote EMT and metastasis in breast cancer.
Li Y; Li L; Qin J; Wu J; Dai X; Xu J
Oncogene; 2021 Jan; 40(1):68-84. PubMed ID: 33051597
[TBL] [Abstract][Full Text] [Related]
17. ETS1 induces transforming growth factor β signaling and promotes epithelial-to-mesenchymal transition in prostate cancer cells.
Rodgers JJ; McClure R; Epis MR; Cohen RJ; Leedman PJ; Harvey JM; ; Thomas MA; Bentel JM
J Cell Biochem; 2019 Jan; 120(1):848-860. PubMed ID: 30161276
[TBL] [Abstract][Full Text] [Related]
18. Metformin inhibits the radiation-induced invasive phenotype of esophageal squamous cell carcinoma.
Nakayama A; Ninomiya I; Harada S; Tsukada T; Okamoto K; Nakanuma S; Sakai S; Makino I; Kinoshita J; Hayashi H; Oyama K; Miyashita T; Tajima H; Takamura H; Fushida S; Ohta T
Int J Oncol; 2016 Nov; 49(5):1890-1898. PubMed ID: 27599468
[TBL] [Abstract][Full Text] [Related]
19. APPL proteins promote TGFβ-induced nuclear transport of the TGFβ type I receptor intracellular domain.
Song J; Mu Y; Li C; Bergh A; Miaczynska M; Heldin CH; Landström M
Oncotarget; 2016 Jan; 7(1):279-92. PubMed ID: 26583432
[TBL] [Abstract][Full Text] [Related]
20. The TGF-β signalling negative regulator PICK1 represses prostate cancer metastasis to bone.
Dai Y; Ren D; Yang Q; Cui Y; Guo W; Lai Y; Du H; Lin C; Li J; Song L; Peng X
Br J Cancer; 2017 Aug; 117(5):685-694. PubMed ID: 28697177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]